A 40-year-old female brought to causality by her husband with c/o decreased mental status. She had a knee surgery 3 days back for pain she’s taking oral oxycodone. Her husband noted that she finished the 7 days’ supply during that day only. Patient repoed no seizure activity and there is no H/O of intake of any other drug. On examination patient is afebrile. blood pressure 120/80 mm Hg, Respiratory rate is 3 breath /min with Spo2 = 82%. Patient do not respond to painful stimuli but is able to move all the four extremities. Which of the following drug will you prescribe to improve her mental status?

**Core Concept**
The patient is presenting with signs of respiratory depression, a common side effect of opioid overdose, particularly with the use of oxycodone. The decreased mental status, low respiratory rate, and low oxygen saturation are indicative of opioid-induced respiratory depression.

**Why the Correct Answer is Right**
The patient's symptoms are consistent with opioid-induced respiratory depression, which requires immediate treatment with an opioid antagonist to reverse the effects. Naloxone is a potent opioid antagonist that can rapidly reverse respiratory depression and improve mental status. It works by competitively binding to opioid receptors, thereby blocking the action of opioids and restoring normal breathing patterns.

**Why Each Wrong Option is Incorrect**
**Option A:** **Fentanyl** is a potent opioid, and administering more opioid would worsen the patient's respiratory depression, not improve it.
**Option B:** **Midazolam** is a benzodiazepine, which can further depress respiratory function and worsen the patient's condition.
**Option C:** **Doxapram** is a respiratory stimulant, but it is not as effective as naloxone in reversing opioid-induced respiratory depression and can cause side effects like hypertension and tachycardia.

**Clinical Pearl / High-Yield Fact**
Naloxone is a lifesaving medication in cases of opioid overdose, but it can cause withdrawal symptoms in individuals with a history of opioid use. Therefore, it is essential to monitor patients closely after administering naloxone and provide supportive care as needed.

**Correct Answer: C. Naloxone**

✓ Correct Answer: D. Naloxone